Back to "A positive response is defined as either..."
Claim
Strong Opposition
causal
Analysis v3

In adults with mild-to-moderate Graves’ eye disease living in areas with adequate selenium levels, taking 200 micrograms of sodium selenite daily for six months leads to more patients showing...

0
Pro
62
Against

Mechanism

Synthesis from 1 study

How it works

Selenium helps the body shut down harmful oxidative damage in the eye socket, which calms the immune system's attack on eye tissues. This reduces swelling and redness, improving how patients feel and look. Vitamin B complex may help too, but it doesn't work as directly or powerfully.

Most probable mechanism

In Simple Terms

Selenium boosts the body's ability to neutralize harmful oxidative molecules in the eye socket, which calms down the immune attack on eye tissues, leading to less swelling, redness, and discomfort.

Causal chain
1

Sodium selenite is absorbed and incorporated into selenocysteine for synthesis of selenoproteins

Verified by multiple studies
which leads to
2

Selenoproteins, especially glutathione peroxidases, neutralize reactive oxygen species produced during autoimmune inflammation in orbital tissues

Supported by evidence
which leads to
3

Reduced reactive oxygen species decrease activation of orbital fibroblasts and infiltration of immune cells, lowering production of pro-inflammatory cytokines

Supported by evidence
which leads to
4

Decreased orbital inflammation reduces eyelid swelling, conjunctival redness, and tissue protrusion, improving clinical activity score and quality of life

Verified by multiple studies

Less supported by current evidence, but not ruled out

In Simple Terms

B vitamins help immune cells function properly and directly remove harmful oxidative molecules, which may reduce inflammation in the eye socket.

Causal chain
1

B vitamins act as cofactors for enzymes involved in one-carbon metabolism and mitochondrial energy production in immune cells

Indirect evidence only
which leads to
2

Vitamin B12 directly scavenges reactive oxygen species, reducing oxidative stress in thyroid and orbital tissues

Indirect evidence only
which leads to
3

Reduced oxidative stress and improved immune cell regulation decrease autoantibody production and orbital inflammation

Indirect evidence only
which leads to
4

Lowered inflammation and autoimmunity improve clinical signs and patient-reported quality of life

Verified by multiple studies

Evidence from Studies

Supporting (0)

0

Community contributions welcome

No supporting evidence found

Contradicting (1)

62

Community contributions welcome

62

Efficacy of selenium supplementation for mild-to-moderate Graves’ ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial

Randomized Controlled Trial
Human
2023 Apr 14

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict

Source Study

Efficacy of selenium supplementation for mild-to-moderate Graves’ ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial

Score: 62
DOI: 10.1186/s13063-023-07282-4

Similar Assertions

In people with mild to moderate Graves ophthalmopathy in areas where selenium levels are normal, taking 200 mcg of selenium daily along with vitamin B complex for six months does not lead to a meaningful change in quality of life compared to taking vitamin B complex alone.

76
0
92%

In areas where people have adequate selenium levels, taking vitamin B complex supplements for six months does not significantly improve quality of life or reduce symptoms of mild-to-moderate Graves’ ophthalmopathy.

62
0
90%

In areas where people have adequate selenium levels, taking selenium supplements with vitamin B complex for six months may result in a small reduction in eye inflammation symptoms for Graves’ ophthalmopathy, but the evidence is not conclusive because the study was not blinded.

0
62
90%

In adults with mild to moderate Graves ophthalmopathy in areas where selenium levels are adequate, taking 200 mcg of selenium and vitamin B complex daily for three months is associated with a higher rate of self-reported quality of life improvement compared to no such supplementation, but this difference is not observed after six months.

76
0
90%

Taking 200 micrograms of selenium daily for six months increases the percentage of adults with mild Graves’ ophthalmopathy who achieve no active inflammation, from one-third to just over six in ten, compared to those using only eye drops.

53
0
89%